Patients with gout who did not experience recurrent flares had a shorter mean time between diagnosis and the start of urate-lowering therapy compared with those who had ≥1 flare.

Related Keywords

United Kingdom , Samuel Finnikin , Clinical Practice Research Database , Institute Of Applied Health Research , University Of Birmingham , Applied Health Research ,